VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Peking University People's Hospital
New York Medical College
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Instituto do Cancer do Estado de São Paulo
Children's Hospital of Philadelphia
Case Comprehensive Cancer Center
Roswell Park Cancer Institute
Institut Claudius Regaud
Memorial Sloan Kettering Cancer Center
Fundación de investigación HM
Rezolute
Thomas Jefferson University
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Stanford University
Milton S. Hershey Medical Center
The Netherlands Cancer Institute
Fred Hutchinson Cancer Center
Milton S. Hershey Medical Center
University College, London
M.D. Anderson Cancer Center
Duke University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Asan Medical Center
Asan Medical Center
Asan Medical Center
Baylor College of Medicine
University Hospital Heidelberg
Washington University School of Medicine
Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Asan Medical Center
Children's Hospital of Philadelphia
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Medical University of South Carolina
Memorial Sloan Kettering Cancer Center
Second Affiliated Hospital, School of Medicine, Zhejiang University
UNC Lineberger Comprehensive Cancer Center
Case Comprehensive Cancer Center
NRG Oncology